Dolby Laboratories (DLB) Asset Writedowns and Impairment (2009 - 2026)

Dolby Laboratories' Asset Writedowns and Impairment history runs 18 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• Quarterly Asset Writedowns and Impairment rose 134.36% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 47.98% YoY) and the FY2024 annual result came in at -$2.3 million, down 184.49% from the prior year.
• Asset Writedowns and Impairment was $2.9 million for Q1 2026 at Dolby Laboratories, up from $792000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $16.9 million in Q3 2023 and bottomed at -$2.6 million in Q3 2025.
• A 5-year average of $1.2 million and a median of $631000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment jumped 1132.34% — and 2025, when it sank 2149.21%.
• Dolby Laboratories' Asset Writedowns and Impairment stood at -$1.0 million in 2022, then slumped by 103.98% to -$2.1 million in 2023, then soared by 134.75% to $730000.0 in 2024, then rose by 8.49% to $792000.0 in 2025, then surged by 266.04% to $2.9 million in 2026.
• Business Quant data shows DLB's Asset Writedowns and Impairment at $2.9 million in Q1 2026, $792000.0 in Q4 2025, and -$2.6 million in Q3 2025.